A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.

Boguszewski, Cesar Luiz

A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. [electronic resource] - Pituitary Mar 2012 - 44-9 p. digital

Publication Type: Journal Article

1573-7403

10.1007/s11102-011-0339-7 doi


Adult
Bromocriptine--administration & dosage
Cabergoline
Dopamine Agonists--adverse effects
Echocardiography
Ergolines--adverse effects
Female
Heart Valve Diseases--chemically induced
Humans
Male
Middle Aged
Prolactinoma--drug therapy